Department of Biomedicine, Faculty of Health Sciences, University of Antofagasta, Antofagasta, Chile.
PLoS One. 2013 Dec 2;8(12):e81286. doi: 10.1371/journal.pone.0081286. eCollection 2013.
There are few reports on the role of protein phosphatases during capacitation. Here, we report on the role of PP2B, PP1, and PP2A during human sperm capacitation. Motile sperm were resuspended in non-capacitating medium (NCM, Tyrode's medium, albumin- and bicarbonate-free) or in reconstituted medium (RCM, NCM plus 2.6% albumin/25 mM bicarbonate). The presence of the phosphatases was evaluated by western blotting and the subcellular localization by indirect immunofluorescence. The function of these phosphatases was analyzed by incubating the sperm with specific inhibitors: okadaic acid, I2, endothall, and deltamethrin. Different aliquots were incubated in the following media: 1) NCM; 2) NCM plus inhibitors; 3) RCM; and 4) RCM plus inhibitors. The percent capacitated sperm and phosphatase activities were evaluated using the chlortetracycline assay and a phosphatase assay kit, respectively. The results confirm the presence of PP2B and PP1 in human sperm. We also report the presence of PP2A, specifically, the catalytic subunit and the regulatory subunits PR65 and B. PP2B and PP2A were present in the tail, neck, and postacrosomal region, and PP1 was present in the postacrosomal region, neck, middle, and principal piece of human sperm. Treatment with phosphatase inhibitors rapidly (≤1 min) increased the percent of sperm depicting the pattern B, reaching a maximum of ∼40% that was maintained throughout incubation; after 3 h, the percent of capacitated sperm was similar to that of the control. The enzymatic activity of the phosphatases decreased during capacitation without changes in their expression. The pattern of phosphorylation on threonine residues showed a sharp increase upon treatment with the inhibitors. In conclusion, human sperm express PP1, PP2B, and PP2A, and the activity of these phosphatases decreases during capacitation. This decline in phosphatase activities and the subsequent increase in threonine phosphorylation may be an important requirement for the success of sperm capacitation.
关于蛋白磷酸酶在精子获能过程中的作用鲜有报道。本文报道了蛋白磷酸酶 2B(PP2B)、蛋白磷酸酶 1(PP1)和蛋白磷酸酶 2A(PP2A)在人精子获能过程中的作用。将有活力的精子悬浮于非获能培养基(NCM,含白蛋白和碳酸氢盐的 Tyrode 液)或重建培养基(RCM,含 2.6%白蛋白/25 mM 碳酸氢盐的 NCM)中。通过 Western blot 评估磷酸酶的存在,通过间接免疫荧光评估其亚细胞定位。通过用特定抑制剂孵育精子来分析这些磷酸酶的功能:冈田酸、I2、内皮素和溴氰菊酯。将不同等分试样孵育于以下培养基中:1)NCM;2)含抑制剂的 NCM;3)RCM;4)含抑制剂的 RCM。使用金霉素试验和磷酸酶检测试剂盒分别评估获能精子的百分率和磷酸酶活性。结果证实了 PP2B 和 PP1 在人精子中的存在。我们还报告了 PP2A 的存在,特别是催化亚基和调节亚基 PR65 和 B。PP2B 和 PP2A 存在于尾部、颈部和顶体后区,PP1 存在于顶体后区、颈部、中段和主段。用磷酸酶抑制剂处理可迅速(≤1 分钟)增加呈现 B 型模式的精子比例,达到约 40%的最大值,且在孵育过程中保持不变;3 小时后,获能精子的比例与对照组相似。在获能过程中,磷酸酶的酶活性降低,但其表达没有变化。用抑制剂处理后,丝氨酸残基的磷酸化模式急剧增加。总之,人精子表达 PP1、PP2B 和 PP2A,这些磷酸酶的活性在获能过程中降低。磷酸酶活性的下降和随后丝氨酸磷酸化的增加可能是人精子获能成功的重要要求。